River BioMedics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$2.2M
- Investors
-
6
River BioMedics General Information
Description
Developer of three-D cardiac models intended to offer new human cardiac models for target validation during drug discovery. The company provides highly informative, clinically relevant readouts, granting an in-depth understanding of the effects of compounds on overall cardiac function and screening tools, enabling healthcare professionals to target validation for the discovery and development of novel cardiac drugs.
Contact Information
Website
www.riverbiomedics.comCorporate Office
- Office ZH124
- Drienerlolaan 5
- 7522 NB Enschede
- Netherlands
Corporate Office
- Office ZH124
- Drienerlolaan 5
- 7522 NB Enschede
- Netherlands
River BioMedics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Seed Round | 07-May-2023 | $2.2M | Completed | Product Development | ||
| 4. Seed Round | 20-Jan-2022 | Completed | Product Development | |||
| 3. Grant | 20-Feb-2020 | Completed | Product Development | |||
| 2. Accelerator/Incubator | 08-Oct-2018 | Completed | Startup | |||
| 1. University Spin-Out | 01-Jan-2018 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
River BioMedics Patents
River BioMedics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12584085-B2 | Microfluidic device for a 3d tissue structure | Active | 09-Apr-2020 | ||
| US-20230137145-A1 | Microfluidic device for a 3d tissue structure | Active | 09-Apr-2020 | ||
| WO-2021206551-A1 | Microfluidic device for a 3d tissue structure | Inactive | 09-Apr-2020 | C12M21/08 |
River BioMedics Signals
River BioMedics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Libertatis Ergo Holding (LEH) | Venture Capital | Minority | ||
| BioGeneration Ventures | Venture Capital | Minority | ||
| KIKK Capital | Venture Capital | Minority | ||
| Oost NL | Venture Capital | Minority | ||
| Netherlands Organisation for Scientific Research (Netherlands) | Government |
River BioMedics FAQs
-
When was River BioMedics founded?
River BioMedics was founded in 2018.
-
Where is River BioMedics headquartered?
River BioMedics is headquartered in Enschede, Netherlands.
-
What is the size of River BioMedics?
River BioMedics has 11 total employees.
-
What industry is River BioMedics in?
River BioMedics’s primary industry is Drug Discovery.
-
Is River BioMedics a private or public company?
River BioMedics is a Private company.
-
What is River BioMedics’s current revenue?
The current revenue for River BioMedics is .
-
How much funding has River BioMedics raised over time?
River BioMedics has raised $4.25M.
-
Who are River BioMedics’s investors?
Libertatis Ergo Holding (LEH), BioGeneration Ventures, KIKK Capital, Oost NL, and Netherlands Organisation for Scientific Research (Netherlands) are 5 of 6 investors who have invested in River BioMedics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process